| Code | 5229E |
| MA number | EU/1/23/1770/001 |
| Product Form: | sol inj 1x1,1 ml/44 mg (liek.inj.skl.) |
| MA Status: | Ex - Conditional centralised marketing authorisation |
| Type of procedure: | EU |
| MAH, country: | Pfizer Europe MA EEIG, Belgium |
| Shelf life: | 24 |
| Container: | glass vial |
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 07.12.2023 |
| Validity: | 07.12.2024 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Elrexfio_Karta pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 05.01.2024 |
